PPAR-Gamma agonist rosiglitazone is neuroprotective after stroke in type II diabetic rodents

被引：0
作者：
Vemuganti, R. [1 ]
Tureyen, K. [1 ]
Satriotomo, I. [1 ]
Bowen, K. [1 ]
Kapadia, R. [1 ]
Feinstein, D. [2 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Univ Illinois, Dept Anesthesiol, Chicago, IL USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2009年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [41] PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats
    Zhang, Qin
    Hu, Wenzhi
    Meng, Bin
    Tang, Tiansi
    NEUROLOGICAL RESEARCH, 2010, 32 (08) : 852 - 859
  • [42] Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis
    Lim, Soo
    Lee, Kuy-Sook
    Lee, Jie Eun
    Park, Ho Seon
    Kim, Kyoung Min
    Moon, Jae Hoon
    Choi, Sung Hee
    Park, Kyong Soo
    Kim, Young Bum
    Jang, Hak Chul
    ATHEROSCLEROSIS, 2015, 243 (01) : 107 - 119
  • [43] PPAR-gamma Ligands are neuroprotective against glutamate induced cytotoxicity in retinal ganglion cells
    Aoun, P
    Patel, NJ
    Simpkins, JW
    Agarwal, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U161 - U161
  • [44] The PPAR gamma agonist rosiglitazone reverses the persistent fibrotic phenotype of scleroderma fibroblasts
    Shi-Wen, X.
    Eastwood, M.
    Denton, C. P.
    Leask, A.
    Abraham, D. J.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2010, 91 (02) : A20 - A21
  • [45] Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non-hypertensive diabetic rats
    Abou Daya, Khodor
    Abu Daya, Hussein
    Eddine, Mohamad Nasser
    Nahhas, Georges
    Nuwayri-Salti, Nuha
    JOURNAL OF DIABETES, 2015, 7 (01) : 85 - 94
  • [46] Influence of PPAR-gamma agonist pioglitazone on portal hypertensive syndrome, angiogenic and proinflammatory markers
    Payer, Berit A.
    Reiberger, Thomas
    Schwabl, Philipp
    Fuhrmann, Valentin
    Horvatits, Thomas
    Hummel, Thomas
    Mitterhauser, Markus
    Angermayr, Bernhard
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2012, 56 : 743A - 743A
  • [47] Neuroprotective and Antioxidant Effects of a PPAR-alpha Agonist in Diabetic Retinopathy
    Moran, Elizabeth P.
    Ding, Lexi
    Cheng, Rui
    Wang, Zhongxiao
    Chen, Qian
    Takahashi, Yusuke
    Ma, Jian-Xing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [48] Proteomics and DTI Tractography Analyses for Evaluation PPAR-Gamma Agonist Treatment for Cocaine Dependence
    Tannu, Nilesh S.
    Schmitz, Joy M.
    Lane, Scott D.
    Khader, Hasan M.
    Ponnada, Narayana A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 323S - 323S
  • [49] The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome
    Mullan, KR
    Leslie, H
    McCance, DR
    Sheridan, B
    Atkinson, AB
    CLINICAL ENDOCRINOLOGY, 2006, 64 (05) : 519 - 522
  • [50] COMPARISON OF THE ANTI-INFLAMMATORY AND THERAPEUTIC ACTIONS OF PPAR-GAMMA AGONISTS ROSIGLITAZONE AND TROGLITAZONE IN EXPERIMENTAL COLITIS
    Celinski, K.
    Dworzanski, T.
    Fornal, R.
    Korolczuk, A.
    Madro, A.
    Slomka, M.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 63 (06): : 631 - 640
12345